Blog
RSS FeedPosted by Michael Wonder on 04 Mar 2017
Agenda for the 8 March 2017 TC meeting
3 March 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 03 Mar 2017
The scandal of generic drug pricing: drug regulation policies need review
23 February 2017 - We welcome the news that the Competitions and Market Authority is now taking drug companies such as ...
Posted by Michael Wonder on 03 Mar 2017
How to slash half a billion dollars a year from Australia’s drugs bill
3 March 2017 - Australia is spending more than A$500 million a year too much for pharmaceuticals because of a ...
Posted by Michael Wonder on 02 Mar 2017
NICE expands positive recommendation for Erbitux as first-line treatment for RAS wild type mCRC
2 March 2017 - NICE’s recommendation is a significant step forward in Merck’s aspiration to ensure cancer patients have optimal ...
Posted by Michael Wonder on 02 Mar 2017
NICE recommends Ocaliva (obeticholic acid) for the treatment of patients with primary biliary cholangitis in England, Wales and Northern Ireland
2 March 2017 - Rapid NICE approval only two months after marketing authorisation in the EU; one of the fastest ...
Posted by Michael Wonder on 02 Mar 2017
Health funds’ hit list to save members $1.5bn a year
3 March 2017 - The private health insurance sector’s peak body has outlined measures in its pre-budget submission that it ...
Posted by Michael Wonder on 02 Mar 2017
NICE says patients accessing more cancer drugs following price drops
2 March 2017 - Patients will have routine access to more cancer drugs as companies have dropped their prices as part ...
Posted by Michael Wonder on 02 Mar 2017
Grant winners announced for new joint pharmaceuticals research fund
2 March 2017 - Researchers from Auckland and Otago Universities are the first recipients of new grants from PHARMAC and ...
Posted by Michael Wonder on 01 Mar 2017
'Give us the chance to live': mum suffering from breast cancer begs for life-extending drug Kadcyla to be available on NHS
1 March 2017 - Lesley Stephen watched her friend Annie die of cancer after being refused the drug and decided to ...
Posted by Michael Wonder on 01 Mar 2017
Palbociclib in advanced breast cancer: disadvantages in certain patients
1 March 2017 - More frequent severe side effects in first-line therapy after menopause/missing data for other patients. ...
Posted by Michael Wonder on 28 Feb 2017
Pharma company gives up on PHARMAC–gives drug free to New Zealand patients
28 February 2017 - Sanofi Genzyme developed Myozyme, a complex biological treatment for Pompe disease, a lysosomal disease, over ten ...
Posted by Michael Wonder on 28 Feb 2017
Pathology providers guarantee to continue to provide Pap Tests for Australian women
28 February 2017 - The Federal Department of Health has reached agreement with representatives of the Australian Pathology providers which will ...
Posted by Michael Wonder on 28 Feb 2017
Universal public coverage of essential drugs would improve health care, research suggests
27 February 2017 - Price of medication for high blood pressure, diabetes sometimes blocks patients' treatment. ...
Posted by Michael Wonder on 28 Feb 2017
NICE publishes draft guidance on Keytruda
28 February 2017 - The Department of Health has asked NICE to produce guidance on using pembrolizumab in the NHS in ...
Posted by Michael Wonder on 28 Feb 2017
PBS website update - 1 March 2017
1 March 2017 - The Schedule of Pharmaceutical Benefits for February 2017 will remain effective until the April 2017 Schedule ...